Results 61 to 70 of about 23,251 (236)

Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends

JEADV Clinical Practice, EarlyView.
ABSTRACT Background There is a growing body of literature suggesting that GLP‐1 receptor agonists (GLP‐1RAs) may be associated with hair loss; however, primary literature is sparse. Additionally, it is not well‐established which types of hair loss may be associated with GLP‐1RA use. Objectives This study aims to assess associations between GLP‐1RAs and
Lauren M. Ching, Christopher A. Guirguis, Joe K. Tung   +2 more
wiley   +1 more source

The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review

Dermatology and Therapy
Alopecia areata is an inflammatory autoimmune disease that presents as non-scarring hair loss in adults and children and causes substantial psychological distress, economic burden, and reduced quality of life for those affected.
Hussein Abdel Dayem, Anwar Al Hammadi, Ashraf Reda, Fatima Albreiki, Ayman Al Naeem, Ahmed Ameen, Mohamed Ahmed, Huda Rajab Ali, Mohamed Elrayes, Gozde Senay, Muna Al Murrawi   +10 more
doaj   +1 more source

Global, Regional, and National Burden of Alopecia Areata and its Associated Comorbidities, 1990–2021, and Projections to 2050: An Analysis of the Global Burden of Disease Study 2021

Acta Dermato-Venereologica
There are no updated epidemiological data on alopecia areata up to 2021. The objective of this study was to emphasize the urgency of addressing the evolving public health challenges of alopecia areata.
Dan Wang, Peizhi Deng, Shengbo Yang, Yangfan Xu, Jianyun Lu   +4 more
doaj   +1 more source

Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata - part II Desafio clínico e histológico no diagnóstico diferencial de alopecia difusa: alopecia androgenética, eflúvio telógeno e alopecia areata - parte II

Anais Brasileiros de Dermatologia, 2012
Diffuse alopecia is mainly caused by telogen effluvium, diffuse androgenetic alopecia (femalepattern hair loss) and diffuse alopecia areata. Differential diagnosis between the three disorders may be difficult in several occasions.
Betina Werner, Fabiane Mulinari-Brenner
doaj   +1 more source

Monitoring chemotherapy-induced alopecia with trichoscopy [PDF]

, 2018
Background: Chemotherapy-induced alopecia (CIA) ranks among the psychologically most devastating effects of cancer treatment for oncological patients, with an overall incidence of 65%. Nowadays trichoscopy is largely employed in the diagnosis of alopecia,
Cardone, Michele, Carlesimo, Marta, Caro, Gemma, Fortuna, Maria Caterina, Garelli, Valentina, Grassi, Sara, Rossi, Alfredo   +6 more
core   +1 more source

Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Alopecia areata (AA) is a chronic autoimmune hair loss disorder. Patients with primary autoimmune diseases commonly use systemic immunomodulators to manage disease and have an increased risk of developing AA. Systemic immunomodulators have diverse immunologic effects, but their impact on AA risk is not well understood. Objectives We
Angela Rose Liu, Nada Hentati, Bethany R. Rohr   +2 more
wiley   +1 more source

Temporal triangular alopecia: A rare entity

Clinical Dermatology Review, 2023
Congenital triangular alopecia (CTA) presents as a localized nonscarring patch of alopecia. It is likely to be confused with alopecia areata. The case is being reported to increase awareness and familiarize clinicians about this rare condition of CTA ...
Sonia P Jain, Dhavalkumar Shivram Bansode, Artilata Deshmukh   +2 more
doaj   +1 more source

Evaluation of Serum Inflammatory Markers and Their Relationship to Treatment Response in Alopecia Areata Patients

Dermatology Practical & Conceptual
Introduction: Alopecia areata is a type of non-scarring alopecia, which is thought to be associated with T-cell mediated immune response. Objective: This study aims to compare the levels of serum inflammatory markers before and after treatment in ...
Icim Komurcugil, Nermin Karaosmanoğlu
doaj   +1 more source

Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?

Dermatology and Therapy, 2023
Background Numerous studies have indicated that alopecia areata is associated with a chronic systemic inflammation, which is considered as a risk factor for venous thromboembolism.
Anna Waśkiel-Burnat, Adriana Rakowska, Michał Zaremba, Magdalena Maciejewska, Leszek Blicharz, Michela Starace, Matilde Iorizzo, Bianca Maria Piraccini, Małgorzata Olszewska, Lidia Rudnicka   +9 more
doaj   +1 more source

Janus Kinase Inhibitors in the Treatment of Alopecia Areata

Prague Medical Report, 2023
Alopecia areata is a disease of autoimmune origin which causes non scarring hair loss. The extent of alopecia varies from a small patch to complete scalp and body hair loss, which can have huge psychosocial impact for those affected. Treatment modalities
Athanasios J. Stefanis
doaj   +1 more source